Format

Send to

Choose Destination
J Natl Compr Canc Netw. 2018 Nov;16(11):1398-1404. doi: 10.6004/jnccn.2018.7081.

Screening Mammography for Average-Risk Women: The Controversy and NCCN's Position.

Abstract

Breast cancer remains the most common nonskin cancer among women and a leading cause of morbidity and mortality. Early detection through screening and advances in treatment have contributed to a 39% mortality reduction in the United States since 1990. The NCCN Guidelines for Breast Cancer Screening and Diagnosis recommend annual mammographic screening for average-risk women beginning at age 40 years. Mammographic screening and subsequent treatment reduces breast cancer mortality based on a wide range of studies. This article highlights NCCN's position on screening mammography and the screening controversy.

PMID:
30442738
DOI:
10.6004/jnccn.2018.7081

Supplemental Content

Full text links

Icon for Sheridan PubFactory
Loading ...
Support Center